Cost-Effectiveness and robustness evaluation for biomanufacturing

BioProcess International

Volumn 11, Issue 11, 2013, Pages 20-27

  Farid, Suzanne S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPROCESS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DESIGN; DRUG MANUFACTURE; DRUG MARKETING; FED BATCH CULTURE; UNCERTAINTY;

EID: 84890259969     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (15)

1. Farid SS. A Decision-Support Tool for Simulating the Process and Business Perspectives of Biopharmaceutical Manufacture (PhD Thesis). University of London: London, UK, 2001
2. Lim AC, et al. Application of a Decision-Support Tool to Assess Pooling Strategies in Perfusion Culture Processes Under Uncertainty. Biotechnol. Progr. 21(4) 2005: 1231-1242
3. Lim AC, et al. A Computer-Aided Approach to Compare the Production Economics of Fed-Batch Versus Perfusion Culture. Biotechnol. Bioeng. 93(4) 2006: 687-697
4. Mustafa MA, et al. Retrofit Decisions Within the Biopharmaceutical Industry: An EBA Case Study. Food Bioprod. Proc. 84, 2006: 84-89
5. Farid SS, Washbrook J, Titchener- Hooker NJ. Combining Multiple Quantitative and Qualitative Goals When Assessing Biomanufacturing Strategies Under Uncertainty. Biotechnol. Progr. 21(4) 2005: 1183-1191
6. Farid SS, Washbrook J, Titchener-Hooker NJ. Decision-Support Tool for Assessing Bio- Manufacturing Strategies Under Uncertainty: Stainless Steel Versus Disposable Equipment for Clinical Trial Material Preparation. Biotechnol. Progr. 21(2) 2005: 486-497
7. Farid SS, Washbrook J, Titchener- Hooker NJ. Modelling Biopharmaceutical Manufacture: Design and Implementation of SIMBIOPHARMA. Comput. Chem. Eng. 31, 2007: 1141-1158
8. Stonier A, et al. Decisional Tool to Assess Current and Future Process Robustness in an Antibody Purification Facility. Biotechnol. Progr. 28(4) 2012: 1019-1028
9. Pollock J, Ho SV, Farid SS. Fed-Batch and Perfusion Culture Processes: Operational, Economic and Environmental Feasibility Under Uncertainty. Biotechnol. Bioeng. 110(1) 2013: 206-219
10. Rajapakse A, Titchener-Hooker NJ, Farid SS. Modelling of the Biopharmaceutical Drug Development Pathway and Portfolio Management. Comput. Chem. Eng. 29(6) 2005: 1357-1368
11. Rajapakse A, Titchener-Hooker NJ, Farid SS. Integrated Approach to Improving the Value Potential of Biopharmaceutical R&D Portfolios While Mitigating Risk. J. Chem. Technol. Biotechnol. 81, 2006: 1705-1714
12. George ED, Farid SS. Stochastic Combinatorial Optimisation Approach to Biopharmaceutical Portfolio Management. Industr. Eng. Chem. Res. 47(22) 2008: 8762- 8774
13. George ED, Farid SS. Strategic Biopharmaceutical Portfolio Development: An Analysis of Constraint-Induced Implications. Biotechnol. Progr. 24(3) 2008: 698-713
14. Lakhdar K, et al. Multiobjective Long Term Planning of Biopharmaceutical Manufacturing Facilities. Biotechnol. Progr. 23(6) 2007: 1383-1393
15. Titchener-Hooker NJ, Dunnill P, Hoare M. Micro Biochemical Engineering to Accelerate the Design of Industrial-Scale Downstream Processes for Biopharmaceutical Proteins. Biotechnol. Bioeng. 100(3) 2008: 473- 487